( NASDAQ-NMS:RGLS )

News from Regulus Therapeutics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 08, 2017, 17:00 ET Regulus to Present at the 2017 Wedbush PacGrow Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Aug 01, 2017, 16:10 ET Regulus Reports Second Quarter 2017 Financial Results and Recent Events

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jul 25, 2017, 16:05 ET Regulus Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company developing innovative medicines targeting microRNAs, today announced the...


Jul 25, 2017, 08:30 ET Regulus to Provide Second Quarter 2017 Financial Results on August 1, 2017

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jul 19, 2017, 21:45 ET Regulus Announces Pricing of Public Offering of Common Stock

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company developing innovative medicines targeting microRNAs, today...


Jul 19, 2017, 16:01 ET Regulus Announces Commencement of Public Offering of Common Stock

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company developing innovative medicines targeting microRNAs, today announced...


Jun 13, 2017, 08:30 ET Regulus Promotes Mark Deeg, M.D. PhD to Chief Medical Officer

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jun 12, 2017, 07:00 ET Regulus Announces Pipeline Updates and Advancements

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jun 01, 2017, 16:15 ET Pascale Witz Joins Regulus Board of Directors

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


May 04, 2017, 16:30 ET Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Apr 27, 2017, 16:10 ET Regulus to Provide First Quarter 2017 Financial Results on May 4, 2017

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Mar 28, 2017, 08:30 ET Regulus to Present at the 16th Annual Needham Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Mar 02, 2017, 16:10 ET Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Feb 23, 2017, 16:10 ET Regulus to Release Fourth Quarter and Full Year 2016 Financial Results on March 2, 2017

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines...


Feb 16, 2017, 08:30 ET Regulus Announces Publication in Nature Communications Identifying miR-17 as a Promising Drug Target for ADPKD

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Feb 08, 2017, 16:10 ET Regulus to Present at Upcoming Healthcare Conferences

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jan 27, 2017, 16:10 ET Regulus Announces Continuation of RG-101 Clinical Hold

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Dec 06, 2016, 16:10 ET Regulus Announces New Drug Development Candidates

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Nov 22, 2016, 08:00 ET Regulus to Announce New Drug Development Candidates at R&D Day on December 6, 2016

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Nov 01, 2016, 16:10 ET Regulus Reports Third Quarter 2016 Financial Results

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Oct 25, 2016, 16:15 ET Regulus to Release Third Quarter Financial Results on November 1, 2016

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Oct 06, 2016, 16:15 ET Regulus Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Oct 05, 2016, 08:00 ET Regulus Appoints Timothy M. Wright, M.D. as Chief Research and Development Officer

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Aug 31, 2016, 08:00 ET Regulus to Present at the 2016 Wells Fargo Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Aug 09, 2016, 16:10 ET Regulus to Present at the 2016 Wedbush PacGrow Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...